| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Brian Rayner | |
| P2860 | cites work | Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators | Q28144781 |
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data | Q30656350 | ||
| Telmisartan, ramipril, or both in patients at high risk for vascular events | Q33156143 | ||
| Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials | Q34228562 | ||
| Renal and retinal effects of enalapril and losartan in type 1 diabetes | Q34296719 | ||
| Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. | Q34299778 | ||
| The burden of non-communicable diseases in South Africa | Q34999659 | ||
| Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review | Q35905849 | ||
| Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET--a call for more circumspection | Q37355390 | ||
| Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial | Q43626458 | ||
| Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial | Q44280775 | ||
| Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community | Q44514221 | ||
| Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region | Q44676613 | ||
| South African hypertension guideline 2006. | Q46169385 | ||
| Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. | Q46426098 | ||
| Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis | Q46555031 | ||
| Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? | Q50657801 | ||
| Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies | Q57704023 | ||
| Diabetic nephropathy: can renoprotection be extrapolated to cardiovascular protection? | Q74578281 | ||
| Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes | Q77550006 | ||
| Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis | Q81161791 | ||
| The COOPERATE trial: a letter of concern | Q81245976 | ||
| Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease | Q81555894 | ||
| Diabetes complications and the renin-angiotensin system | Q84155268 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3-6 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Cardiovascular Journal of Africa | Q26830987 |
| P1476 | title | Do inhibitors of the rennin-angiotensin system prevent chronic kidney disease? | |
| P478 | volume | 21 |
Search more.